A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment-Reference-Cited by-同舟云学术

A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment

Published:2019-03-28 Issue:8 Volume:59 Page:1110-1119
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Taylor Lesley¹,Crockett Julie¹,Tayo Bola¹,Morrison Gilmour¹

Affiliation:

1. GW Research Ltd Cambridge United Kingdom

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1412

Reference25 articles.

1. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

2. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

3. Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

4. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

5. EPIDIOLEX USPI.Highlights of prescribing information: EPIDIOLEX® (cannabidiol) oral solution.https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210365lbl.pdf. Accessed September 5 2018.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of cannabidiol-induced cytotoxicity in human hepatic cells;Toxicology;2024-08

2. Metabolism and liver toxicity of cannabidiol;Journal of Environmental Science and Health, Part C;2024-06-21

3. Quantitative summary on the human pharmacokinetic properties of cannabidiol to accelerate scientific clinical application of cannabis;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-08

4. Physiological profiling of cannabidiol reveals profound inhibition of sensory neurons;Pain;2024-05-29

5. Decoding epilepsy treatment: A comparative evaluation contrasting cannabidiol pharmacokinetics in adult and paediatric populations;Chemico-Biological Interactions;2024-05